|
November 16, 2019: Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Study of a Novel Platelet Glycoprotein IIB/IIIA Inhibi |
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Study of a Novel Platelet Glycoprotein IIB/IIIA Inhibitor Designed for Point of Care ST-Segment Myocardial Infarction Treatment
TBA
[ Download video ] |
|
No comments have been submitted
|